Dimensional Fund Advisors LP Enanta Pharmaceuticals Inc Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 277,640 shares of ENTA stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277,640
Previous 282,302
1.65%
Holding current value
$3.06 Million
Previous $1.56 Million
34.66%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ENTA
# of Institutions
107Shares Held
18.7MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$23.4 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$23.3 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$21.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$20.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.46MShares$16.1 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $228M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...